利格列汀雜質 結構確證 返回列表頁

中文名稱

英文名稱

利格列汀標準品

Linagliptin

利格列汀雜質1

2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide

利格列汀雜質2

(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

利格列汀雜質3

N-Phthalimide-linagliptin

利格列汀雜質4

N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide

利格列汀雜質5

(R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid

利格列汀雜質6

8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1)

利格列汀雜質7

Linagliptin Diene Impurity

利格列汀雜質8

Linagliptin Acetamide

利格列汀雜質9

(R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

利格列汀雜質10

(R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione

利格列汀雜質11

8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

利格列汀雜質12

(R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

利格列汀雜質13

(R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

利格列汀雜質14

(R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione

利格列汀雜質15

(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide

利格列汀雜質16

(S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

利格列汀雜質17

(S)-Linagliptin

利格列汀雜質18

N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide

利格列汀雜質19

(R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

利格列汀雜質20

(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide

利格列汀雜質21

(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

利格列汀雜質22

(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione

利格列汀雜質23

(S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate

利格列汀雜質24

(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

利格列汀雜質25

(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide

2573

Lead Paint Film (Red), Nominal 1.0 mg/cm2

1 +blank

90

Ferrophosphorus

75 g

2585

Organic Contaminants in House Dust

10 g

915b

Calcium Carbonate 

20 g

659

Particle Size Distribution Standard for Sedigraph Calibration

set (5)

3109a

Calcium (Ca) Standard Solution

5 x 10 mL

3671

Nicotine Metabolites in Human Urine (Frozen)

3 x 10 mL

1048

Cup Furnace Smoke Toxicity Method Standard

8 sheets

72g

Low Alloy Steel (AISI 4130)

150 g

C2418

High-Purity Lead

disk

3669

Arsenic Species in Frozen Human Urine (Elevated Levels)

5 x 1.5mL

1754

Low-Alloy Steel, AISI 4320

rod

1544

Fatty Acids and Cholesterol in a Frozen Diet Composite

4x15 g

2113

Dynamic Impact Force Verification Specimens (Nominal 33kN)

set

882

Nickel-Copper Alloy (65Ni-31Cu-3Al)

100 g

1075a

Aluminum 2-Ethylhexanoate

5 g

1958

Organic Contaminants in Fortified Human Serum (Freeze-Dried)

5 x 10 mL

423

Molybdenum Oxide Concentrate

1 pouch x 60 g

3117a

Europium (Eu) Standard Solution

5x10 mL

1484a

Linear Polyethylene

0.3 g

2841

Semiconductor Thin Film: AlxGa1-xAs Epitaxial Layers (Al mole fraction x near 0.20)

disk

2580

Powdered Paint Nominal 4% Lead

30 g

858

Aluminum Alloy 6011

35 g

154c

Titanium Dioxide

90 g

17f

Sucrose Optical Rotation

60 g